Detalhe da pesquisa
1.
Cardiometabolic risk factors and antithrombotic treatment in a Mexican population with atrial fibrillation and heart failure with reduced ejection fraction.
Gac Med Mex
; 159(1): 24-31, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-36930551
2.
Atrial fibrillation in Mexican population: Differences in presentation, comorbidities and risk factors between men and women / Fibrilación auricular en población mexicana: Diferencias en presentación, comorbilidades y factores de riesgo entre hombres y mujeres
Arch Cardiol Mex
; 92(3): 349-357, 2022 07 01.
Artigo
Espanhol
| MEDLINE | ID: mdl-34758015
3.
Familial hypercholesterolemia in Mexico: Initial insights from the national registry.
J Clin Lipidol
; 15(1): 124-133, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33422452
4.
Anticoagulation Therapy by Age and Embolic Risk for Nonvalvular Atrial Fibrillation in Mexico, an Upper-Middle-Income Country: The CARMEN-AF Registry.
Glob Heart
; 15(1): 32, 2020 04 10.
Artigo
Inglês
| MEDLINE | ID: mdl-32489805
5.
Factores de riesgo cardiometabólico y tratamiento antitrombótico en población mexicana con fibrilación auricular e insuficiencia cardiaca con fracción de expulsión reducida / Cardiometabolic risk factors and antithrombotic treatment in a Mexican population with atrial fibrillation and heart failure with reduced ejection fraction
Gac. méd. Méx
; 159(1): 24-31, ene.-feb. 2023. tab, graf
Artigo
Espanhol
|
LILACS-Express
| ID: biblio-1448261